Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3 results about "Naphthalene Compound" patented technology

A class of compounds with the basic naphthalene structure, an aromatic hydrocarbon compound, consisting of two fused benzene rings.

A binaphthyl compound, its preparation method and use thereof

This invention discloses a binaphthyl compound, its preparation method, and its applications. The structural formula of the binaphthyl compound is shown in any one of formulas A1-A5. In the technical solution of this invention, an organic phosphorescent molecule is developed by rationally designing its molecular structure, maintaining an appropriate energy level difference between the singlet and triplet excited states, enabling effective intersystem crossing (ISC) from the singlet to the triplet excited state; and by creating a rigid environment, the non-radiative deactivation of the triplet excited state of the organic phosphorescent molecule is suppressed, thereby obtaining efficient, stable, and long-lived phosphorescence.
Owner:TECHNICAL INST OF PHYSICS & CHEMISTRY - CHINESE ACAD OF SCI

Oligomeric binaphthyl compounds and thermoplastic resins

The present invention relates to the use of the compound of the formula (I) where the variables are as defined in the claims and the description, or of a mixture thereof, as a monomer for producing a thermoplastic resin selected from polyesters, polycarbonates and polyestercarbonates. The invention relates moreover to compounds (I), except for compounds where A1 and A2 are both unsubstituted 1,4-phenylene, p and q are both 0, and X1 and X2 are both —CH2OH or —C(O)OH, and except for the compound where A1 and A2 are both unsubstituted 2,3-quinolinylene, p and q are both 0, and X1 and X2 are both —CH2OH.
Owner:MITSUBISHI GAS CHEM CO INC

Octahydro fused azadecalin glucocorticoid receptor modulators

PendingEP4717266A3Organic active ingredientsNervous disorderPharmaceutical drugGlucocorticoid receptor binding
The present invention provides octahydro fused azadecalin compounds having glucocorticoid receptor binding affinity and modulatory activity for pharmaceutical use Also provided are pharmaceutical compositions containing an effective amount of the fused azedecalin compounds and methods of using the compositions for the-treatment of a glucocorticoid receptor mediated disorder in a subject.
Owner:CORCEPT THERAPEUTICS INC